Innate Pharma SA Current Value Added Tax Receivables
Innate Pharma SA (IPHA) had Current Value Added Tax Receivables of EUR 909.00 thousand as of 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Receivables
ifrs-full:CurrentValueAddedTaxReceivables · last filed 2026-04-01
- 2025-12-31: Current Value Added Tax Receivables 909.00K EUR.
- 2025-06-30: Current Value Added Tax Receivables 695.00K EUR.
- 2024-12-31: Current Value Added Tax Receivables 880.00K EUR.
- 2024-06-30: Current Value Added Tax Receivables 583.00K EUR.
| Period end | Current Value Added Tax Receivables |
|---|---|
| 2025-12-31 | 909.00K EUR 20-F · filed 2026-04-01 |
| 2025-06-30 | 695.00K EUR 6-K · filed 2025-09-17 |
| 2024-12-31 | 880.00K EUR 20-F · filed 2026-04-01 |
| 2024-06-30 | 583.00K EUR 6-K · filed 2024-09-12 |
| 2023-12-31 | 1.04M EUR 20-F · filed 2026-04-01 |
| 2023-06-30 | 1.72M EUR 6-K · filed 2023-09-14 |
| 2022-12-31 | 1.61M EUR 20-F · filed 2025-04-30 |
| 2022-06-30 | 1.54M EUR 6-K · filed 2022-09-15 |
| 2021-12-31 | 1.17M EUR 20-F · filed 2024-04-04 |
| 2021-06-30 | 1.73M EUR 6-K · filed 2021-09-15 |
| 2020-12-31 | 2.21M EUR 20-F · filed 2023-04-06 |
| 2019-12-31 | 2.00M EUR 20-F · filed 2022-04-04 |
| 2018-12-31 | 2.81M EUR 20-F · filed 2021-04-27 |
| 2017-12-31 | 2.67M EUR 20-F · filed 2020-04-24 |